secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2026-01-21T23:59:59+00:00
Accession:  0001213900-26-006281
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed faces Nasdaq delisting after failing minimum bid price; appeals with reverse split plan
--------------------------------------------------------------------------------

- Failed to regain minimum $1.00 bid price by Jan 14, 2026; Nasdaq notified delisting effective Jan 27, 2026.
- Company appealed on Jan 21, 2026, staying suspension pending Nasdaq hearings panel decision.
- Regain compliance plan includes reverse stock split approved Jan 12, 2026, effective on/after Feb 13, 2026.
- No assurance that panel will grant continued listing or that compliance will be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026006281/0001213900-26-006281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026006281/ea027358501-8k_advanced.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-006281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer